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Vaccinia virus (VACV) is a large DNA virus that replicates in the cytoplasm and encodes about 200
proteins of which approximately 50% may be non-essential for viral replication. These proteins
enable VACV to suppress transcription and translation of cellular genes, to inhibit the innate immune
response, to exploit microtubule- and actin-based transport for virus entry and spread, and to
subvert cellular metabolism for the benefit of the virus. VACV strain WR protein C16 induces
stabilization of the hypoxia-inducible transcription factor (HIF)-1a by binding to the cellular oxygen
sensor prolylhydroxylase domain-containing protein (PHD)2. Stabilization of
HIF-1a is induced by several virus groups, but the purpose and consequences are unclear. Here,
1H-NMR spectroscopy and liquid chromatography-mass spectrometry are used to investigate the
metabolic alterations during VACV infection in HeLa and 2FTGH cells. The role of C16 in such
alterations was examined by comparing infection to WT VACV (strain WR) and a derivative virus
lacking gene C16L (vDC16). Compared with uninfected cells, VACV infection caused increased
nucleotide and glutamine metabolism. In addition, there were increased concentrations of glutamine
derivatives in cells infected with WT VACV compared with vDC16. This indicates that C16
contributes to enhanced glutamine metabolism and this may help preserve tricarboxylic acid cycle
activity. These data show that VACV infection reprogrammes cellular energy metabolism towards
increased synthesis of the metabolic precursors utilized during viral replication, and that C16
contributes to this anabolic reprogramming of the cell, probably via the stabilization of HIF-1a.
INTRODUCTION
Vaccinia virus (VACV) is the prototypic member of the
genus Orthopoxvirus of the family Poxviridae. VACV is also
the live vaccine used to eradicate smallpox (Fenner et al.,
1988). Long after smallpox eradication, VACV is still studied
intensively due to its role in vaccine development and
because VACV is an excellent model for studying virus–host
interactions, such as immune evasion (Smith et al., 2013).
VACV is a large, dsDNA virus encoding about 200 genes
(Goebel et al., 1990) that replicates in the cytoplasm (Moss,
2007) and reprogrammes cell biochemistry to favour viral
replication. For example, VACV encodes a growth factor
(Twardzik et al., 1985) that stimulates the metabolism of
resting cells (Buller et al., 1988a, b) and several enzymes
involved in nucleotide metabolism, such as ribonucleotide
reductase (Slabaugh et al., 1988; Tengelsen et al., 1988),
thymidine kinase (Hruby & Ball, 1982; Weir et al., 1982),
thymidylate kinase (Hughes et al., 1991; Smith et al., 1989b),
dUTPase (Broyles, 1993; McGeoch, 1990) and uracil
DNA glycosylase (De Silva & Moss, 2003, 2008). VACV
also encodes three thiol oxidoreductases enabling protein
disulphide bond formation (Senkevich et al., 2002; White
et al., 2000), a steroid biosynthetic enzyme to suppress
inflammation (Moore & Smith, 1992; Reading et al., 2003),
protein kinases (Banham & Smith, 1992; Lin & Broyles, 1994;
Lin et al., 1992; Rempel & Traktman, 1992), a phosphatase
(Guan et al., 1991), DNA ligase (Colinas et al., 1990; Kerr &
Smith, 1989; Smith et al., 1989a) and topoisomerase
(Shuman & Moss, 1987). For a review of enzymes involved
in DNA replication, see Moss (2013). Very recently, two
studies reported increased glutamine utilization (Fontaine
et al., 2014) and de novo fatty acid biosynthesis (Greseth &
Traktman, 2014) during VACV infection.
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VACV protein C16 is an intracellular virulence factor (Fahy
et al., 2008) that binds the cellular oxygen sensor prolyl-
hydroxylase domain-containing protein (PHD)2, thereby
preventing hydroxylation and consequent degradation of
hypoxia-inducible transcription factor (HIF)-1a during
normoxia (Mazzon et al., 2013). HIF-1a is a transcriptional
regulator of oxygen homeostasis. During hypoxia, HIF-1a is
stabilized and translocates into the nucleus where it induces
transcription of numerous genes. These include genes
encoding proteins that promote oxygen uptake, by inducing
angiogenesis and erythropoiesis, and decreasing oxygen
consumption, by switching metabolism from oxidative
phosphorylation, which generates ATP and consumes oxygen
in the mitochondrion, to glycolysis (Semenza, 2012).
Interestingly, HIF-1a stabilization and the consequent
metabolic shift occur during normoxia in several physio-
logical and pathological conditions, particularly in rapidly
proliferating cells, or upon infection with several viral and
non-viral pathogens (Carroll et al., 2006; Tang et al., 2007;
Werth et al., 2010). These observations suggest there are other
advantages to pathogens from HIF-1a stabilization beyond
regulation of oxygen homeostasis, as reviewed by Chen &
Russo (2012). It is possible that HIF-1a stabilization might
play a role in VACV reprogramming of cellular metabolism.
The emerging field of viral metabolomics is helping explain
how viruses reprogramme cell metabolism to assist viral
replication (Diamond et al., 2010; Heaton et al., 2010;
Vastag et al., 2011). Here, a combination of proton nuclear
magnetic resonance (1H-NMR) spectroscopy and liquid
chromatography-mass spectrometry (LC-MS) is used to
investigate the metabolic alterations induced by VACV
infection in two cell types, focusing on alterations in energy
metabolism that might be influenced by stabilization of HIF-
1a. An increase in nucleotides and intermediates of glucose
and glutamine metabolism was observed. Interestingly, no
increase in lactate production or decrease in tricarboxylic
acid (TCA) cycle activity was seen, as might have been
expected following stabilization of HIF-1a. Moreover, the
increase in glutamine metabolism following infection with
WT VACV was much diminished following infection with a
virus-lacking gene C16L (vDC16), implicating protein C16
in reprogramming cellular energy metabolism.
RESULTS
Metabolic profile of VACV-infected HeLa cells
HIF-1a stabilization induces alterations in cellular energy
metabolism (Semenza, 2012). Given that VACV protein
C16 induces rapid stabilization of HIF-1a and upregulation
of hypoxia-inducible genes (Mazzon et al., 2013), we
hypothesized that protein C16 might reprogramme cellular
metabolism.
The metabolic alterations following infection by VACV
strain WR or a derivative virus lacking C16 (vDC16) were
characterized in HeLa cells, a human carcinoma cell line
used widely for studying virus infections. Cells were grown
to confluency to reduce cell proliferation and induce some
degree of synchrony, while minimum essential medium
(MEM) with low serum (1%) and low glucose concentra-
tions (1 g l21) was used to reduce cellular metabolic activity.
Cells were mock-infected or infected with VACV or vDC16,
and intracellular aqueous metabolites were extracted and
analysed by 1H-NMR spectroscopy, a technique suitable for
studying central energy metabolism. Partial least squares-
discriminant analysis (PLS-DA) was used to analyse the
datasets. PLS-DA allows analysis and group discrimination
between a large number of variables (here, the concentration
of metabolites), and subsequent identification of the
variables contributing to the discrimination. Results are
expressed in terms of ‘score plots’, which highlight patterns
and clustering among the samples (each point in the plots
represents one sample and there are five replicates per
condition), and ‘loadings’, or ‘assignment lists’, which
indicate the importance of each original variable (metabo-
lite). Metabolites listed on the left-hand side are more
abundant in samples displayed in the negative area of the
t(1) axis, while metabolites listed on the right-hand side are
more abundant in samples in the positive area. It is worth
mentioning that in NMR each metabolite is associated with
more than one signal, and each signal is usually large enough
to be present in two or more adjacent buckets (the discrete
partitions into which each NMR spectrum is divided for
integration). This leads to multiple loading values for each
metabolite, as seen in the ‘redundancy’ of assignment lists
next to the score plots and in the corresponding supple-
mentary tables. Data are presented following standard
presentation criteria as described by van der Werf et al.
(2007), Martin et al. (2007) and Sumner et al. (2007).
In HeLa cells, 27 metabolites were identified (Table S1,
available in the online Supplementary Material). Application
of PLS-DA to the datasets separated mock-infected from WT
VACV (VACV)-infected HeLa cells (Fig. 1a). The assignment
lists at each side of the graphs illustrate global metabolic
changes in the datasets, with metabolites listed on the left
being more important in defining infected samples and
indicating a higher abundance of lipids following VACV
infection (Fig. 1a) or vDC16 (Fig. 1a, c, Tables S2 and S4).
Pairwise comparison also distinguished infection with WT
VACV from vDC16, with higher levels of glutamate,
glutamine, glutathione and taurine in cells infected by WT
VACV (Fig. 1b, Table S3). The differences between these
viruses increased with time, with maximal separation at 5 h
post-infection (pi) (Fig. 1b, c), consistent with the progressive
onset of different metabolic programmes in the presence or
absence of C16, but were not as large as the differences
between infected and mock-infected samples (Fig. 1c).
When measuring concentrations of individual metabolites
with time, lower concentrations of several metabolites,
particularly glutamine and phosphocholine (at each time
point) and glutathione (at 1 and 3 h pi), were measured with
each virus compared with mock-infected samples (Fig. 2a).
The concentration of adenosine increased at 5 h pi for both
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viruses, reaching statistical significance for vDC16 compared
with mock (P,0.001), while levels of glutamine, initially
higher in mock-infected cells, were higher in cells infected
with VACV by 5 h pi (P,0.05) compared with mock.
Surprisingly, in the cells (Fig. 2a) and culture medium (data
not shown), an increase in lactate was not seen after infection
with either virus compared with mock. For WT VACV, this
was unexpected due to the stabilization of HIF-1a that
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Fig. 1. Metabolic profile of HeLa cells. Five T175 flasks of confluent HeLa cells were either infected with VACV or vDC16 or
mock-infected and at the indicated times pi, cells from each flask were analysed separately for 1H-NMR spectroscopy. (a), (b)
and (c) show score plots for the PLS-DA models obtained using data from cells infected with either VACV (red symbols),
vDC16 (green symbols) or mock-infected (blue symbols), at 1, 3 and 5 h pi (diamonds, circles and asterisks, respectively). Each
point in the graph represents one sample. Assignment lists at either side of each score plot show the metabolites responsible
for the separation in the profiles obtained: metabolites listed on the left are more abundant in samples displayed in the negative
area of the t(1) axis, while metabolites listed on the right are more abundant in samples in the positive area. Complete loading
plots are shown in Tables S2, 3 and 4. The model parameters are: R2(X)567%, R2(Y)584.2%, Q2555% (a); R2(X)570.7%,
R2(Y)599%, Q2587.4% (b); and R2(X)565.6%, R2(Y)598.4%, Q2573.5% (c).
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promotes glycolysis. Furthermore, there was no decrease in
TCA cycle activity following infection with either virus, as
indicated by unchanged levels of TCA cycle intermediates
succinate and formate. Changes here might also have been
expected following HIF-1a stabilization.
Even though PLS-DA was able to separate VACV- from
vDC16-infected cells clearly (Fig. 1b), only minor differences
were observed in the concentrations of individual metabolites
in HeLa cells infected with these viruses at these times (Fig.
2a). This indicates that the difference between the two groups
is associated with global changes in the relative abundance of
metabolites within each group, rather than with individual
concentrations. For instance, although assignment lists (Fig.
1b) suggest reduced accumulation of lactate in cells expressing
C16 (i.e. where HIF-1a is stabilized) this is not statistically
significant (Fig. 2a).
For large DNA viruses, DNA replication requires high levels
of nucleotides and it was estimated that VACV synthesizes
10 000 copies of its 200 kbp genome within a few hours in
the cytoplasm (Joklik & Becker, 1964). Some herpes viruses
induce increased nucleotide biosynthesis after infection
(Vastag et al., 2011). An increase in adenosine was seen in
HeLa cells 5 h pi with vDC16 (Fig. 2a) and, therefore, the
nucleotide profile of infected HeLa cells was analysed more
fully by LC-MS and the metabolites identified are shown in
Table S5. As observed by 1H-NMR spectroscopy, several
metabolites were either unchanged or reduced upon
infection (not shown). However, concentrations of TMP,
TDP, dGTP and dATP were significantly higher following
infection (Fig. 2b). Increased concentrations of TMP and
TDP, observed upon infection with either virus, are
consistent with the early expression of the VACV-encoded
thymidine kinase (Hruby & Ball, 1982; Weir et al., 1982) and
thymidylate kinase (Hughes et al., 1991; Smith et al., 1989b).
To verify that global metabolic differences observed
between the two viruses (Fig. 1b) were not attributable to
differences in replication rate, HeLa cells were infected with
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Fig. 2. Comparison of metabolite concentrations in infected HeLa cells. (a) Data obtained as in Fig. 1 are presented graphically to
show the concentration of assigned metabolites from 1–5 h pi in VACV-infected (red line), vDC16-infected (green line) or mock-
infected HeLa cells (blue line). Concentrations are in mM. Data were analysed using a two-way ANOVAwith Bonferroni’s correction.
Apart fromwhere indicated differently, statistical significance is shown for comparisons betweenmock and VACV-infected samples.
Data represent mean±SEM and experiments were performed using five replicates per sample. *P,0.05; **P,0.01; ***P,0.001;
****P,0.0001. (b) Nucleotide concentrations at 5 h pi. HeLa cells (T175 flasks n55) were infected with VACV or vDC16, or were
mock-infected and at 5 h pi samples were processed for LC-MS. The y-axis shows integrated peak areas. Data were analysed using
a one-way ANOVA, *P,0.05; **P,0.01; ***P,0.001. Differences between VACV and vDC16 were non-significant (ns). (c) Viral
DNA synthesis in HeLa cells infected with VACV or vDC16 at 10 p.f.u. per cell. DNA was harvested and quantified at the indicated
times pi. Amplification of viral DNA polymerase DNA was quantified by PCR. One representative of two experiments is shown.
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VACV or vDC16 and viral DNA was quantified by
measuring gene E9L abundance (encoding DNA polymer-
ase, vPOL; Jones & Moss, 1984) by PCR. DNA synthesis
was similar for each virus, with viral DNA accumulating
from shortly after infection and reaching a plateau by 5 h
(Fig. 2c). These data are consistent with a previous report
showing these viruses replicated equally well in vitro (Fahy
et al., 2008), and suggest that differences in the metabolic
profile of cells infected with these viruses are not caused by
different viral DNA replication rates. These data also
indicate that any metabolic alteration observed is unlikely
to affect viral replication in the cultured cells examined.
Characterization of VACV infection in 2FTGH cells
In HeLa cells, significant differences between infected and
mock-infected cells were observed by 1 h pi and were
accompanied by reduction in several metabolites (Fig. 2a),
reminiscent of the rapid shut-down of cellular transcrip-
tion in VACV-infected HeLa cells (Guerra et al., 2003;
Moss, 2007). To investigate if VACV infection altered
intracellular metabolites in other cells, a human fibrosar-
coma cell line, 2FTGH, was utilized. This cell line was
selected because we had observed a slower and more
gradual progression of VACV infection compared to HeLa
cells, and therefore its use increased the opportunity to see
metabolic differences at early time points after viral entry.
Characterization of viral replication (Fig. 3a) and DNA
synthesis (Fig. 3b) showed that each were slightly slower
than in HeLa cells, although at 24 h pi the final difference
in virus titre was quite small. VACV-induced stabilization
of HIF-1a, already described in HeLa cells (Mazzon et al.,
2013), was also seen in 2FTGH cells (Fig. 3c), although this
occurred slightly more slowly than in HeLa cells, with
maximal accumulation between 2 and 6 h pi.
Metabolic profile of 2FTGH cells after infection
To analyse virus-induced metabolic alterations, confluent
2FTGH cells were infected with VACV or vDC16, and
metabolites were measured by 1H-NMR spectroscopy as for
HeLa cells. The 32 metabolites identified are shown in Table
S6. Application of PLS-DA to the datasets separated infected
from mock-infected 2FTGH cells (Fig. 4a, c), but clear
metabolic differences between samples were apparent after
3 h, indicating that metabolic reprogramming is slightly
delayed compared to HeLa cells. Global metabolic changes in
the datasets are illustrated in the assignment lists at each side
of the score plots, which revealed increased concentrations of
glutamine, glutamate, glutathione and the onco-metabolite
2-hydroxyglutarate (2-HG) in infected samples compared to
mock-infected cells (Fig. 4a, c, Tables S7 and S9).
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Fig. 3. Infection of 2FTGH with VACV. HeLa or 2FTGH cells were infected with VACV at 10 p.f.u. per cell and infectious virions
(a) or viral DNA (b) were quantified at the indicated times. (a) Infectious intracellular virions were titrated by plaque assay. (b)
Amplification of gene E9L DNA was quantified by PCR. Data shown are from one representative experiment of two experiments
that gave indistinguishable data. Data were analysed using a two way ANOVA with Bonferroni’s correction. *P,0.05;
**P,0.01. (c) Stabilization of HIF-1a in VACV-infected 2FTGH cells. Cells were infected with VACV at 5 p.f.u. per cell and at
the time points indicated, cells were lysed and the levels of HIF-1a, VACV protein C16 and a-tubulin were analysed by SDS-
PAGE and immunoblotting. Molecular mass markers are indicated on the left in kDa. One representative experiment of two
experiments is shown.
Vaccinia virus reprogramming of energy metabolism
http://vir.sgmjournals.org 399
Downloaded from www.sgmjournals.org by
IP:  131.111.184.102
On: Wed, 02 Sep 2015 11:19:59
As in HeLa cells, PLS-DA also separated cells infected
with VACV and vDC16, but only from 5 h pi (Fig. 4b, c).
Assignment lists show that higher levels of glutamate,
glutamine, and glutathione accumulated in cells infected by
VACV than by vDC16 (Fig. 4b, c, Tables S8 and 9), and this
was consistent with observations in HeLa cells (Fig. 1b, c). 2-
HG is a by-product of reductive carboxylation of glutamine
(Wise et al., 2011) and accumulated in VACV-infected cells,
and was one of the most critical metabolites to discriminate
between VACV and vDC16. Higher abundance of glutamine,
glutamate, glutathione, and 2-HG in cells infected with
VACV indicate a role for C16 in supporting and enhancing
reductive carboxylation of glutamine.
In infected 2FTGH cells several metabolites increased
progressively with time compared to mock-infected cells
(Fig. 5a) and this differed somewhat from the generic decrease
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Fig. 4. Metabolic profile of infected 2FTGH cells. Five T175 flasks of confluent 2FTGH cells were infected with VACV or
vDC16 or were mock-infected and when indicated cells from each flask were analysed separately for 1H-NMR spectroscopy.
(a), (b), and (c) show score plots for the PLS-DA models, obtained using data from cells infected with VACV (red symbols), or
vDC16 (green symbols), or mock-infected (blue symbols) at 1, 3 and 5 h pi (diamonds, circles and asterisks, respectively). Each
point in the graph represents one sample. Assignment lists show the metabolites responsible for the separation in the profiles
obtained: metabolites listed on the left are more abundant in samples displayed in the negative area of the t(1) axis, while
metabolites listed on the right are more abundant in samples on the positive area. Complete loading plots are shown in Tables
S7, S8 and S9. The model parameters are: R2(X)578.7%, R2(Y)564.5%, Q2530.5% (a); R2(X)578.9%, R2(Y)590.1%,
Q2559.7% (b); R2(X)548.1%, R2(Y)588.5%, Q2553.2% (c).
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in themetabolic pool observed in HeLa cells. In particular, the
levels of glutathione, glutamate, AMP, and two products of
glucose metabolism, myo-inositol and UDP-galactose, all
increased in infected 2FTGH cells, consistent with the PLS-
DA. However, consistent with observations in HeLa cells,
there was no significant difference between infected and
mock-infected 2FTGH cells in concentrations of lactate or
TCA cycle intermediates, showing that the stabilization of
HIF-1a does not promote aerobic glycolysis or prevent TCA
cycle activity in these in vitro settings.
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Fig. 5. Comparison of 2FTGH cells infected with VACV or vDC16. (a) Data obtained as in Fig. 4 are presented graphically to
show the concentration of assigned metabolites from 1–5 h pi in VACV-infected (red line), vDC16-infected (green line) or
mock-infected 2FTGH cells (blue line). Concentrations are in mM. Statistical analysis was as in Fig. 2a. (b) Nucleotide
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As also observed in HeLa cells, whilst the PLS-DA analysis
shows profound differences among 2FTGH cells infected
with VACV and vDC16, only minor differences could be
observed in many individual metabolites between these two
groups. This again suggests larger alterations in the relative
abundance of different metabolites within each group,
rather than in the concentrations of individual metabolites.
The nucleotide profile of infected 2FTGH cells also was
analysed in more detail at 5 h pi by LC-MS and compared
to mock-infected cells. As seen by 1H-NMR spectroscopy,
in 2FTGH cells all nucleotides detected were upregulated
during infection, but in particular, significantly higher
concentrations of GTP precursors GMP, GDP, guanine,
guanosine, IMP and deoxyguanosine were observed. A
statistically significant increase in CMP and uracil was also
measured, confirming that in both cell lines VACV
increases the nucleotide pool of infected cells (Fig. 5b).
No differences in the replication rates of VACV and vDC16
was observed in 2FTGH cells (Fig. 5c), confirming that the
differences observed are not dependent on different
replication levels of these viruses.
Metabolic profile of 2FTGH cells at 7 h pi
In 2FTGH cells the differences following infection with
VACV or vDC16 increased with time (as in HeLa cells), and
this is consistent with the progressive accumulation of
different sets of metabolites following infection. In light of
this, and because of the slightly slower stabilization of HIF-1a
in infected 2FTGH cells compared with HeLa cells, the
metabolic differences between 2FTGH cells infected with
VACV, vDC16 or mock-infected were also compared at 7 h
pi (Fig. 6a, b, Table S10). The separation between VACV and
vDC16 had greater statistical significance at 7 h (Q2592.6%,
Fig. 6a) versus 5 h (Q2559.7%, Fig. 4b). In particular, even
though higher levels of intermediates of glutamine meta-
bolism (glutamine, glutamate, 2-HG, glutathione) were
observed following infection with either VACV or vDC16,
significantly higher levels of all these metabolites were
observed upon infection with VACV than vDC16, consistent
with PLS-DA and loading plots. Interestingly, 2-HG
(together with NAD+) increased significantly only during
infection with WT VACV, indicating higher reductive
carboxylation of glutamine in the presence of C16. The
TCA intermediates, succinate and fumarate, remained
similar between mock-infected and infected cells (either
virus), as already observed at all earlier time points in both
cell lines, indicating that the activity of the TCA cycle is
preserved throughout the infection. Higher levels of most
amino acids were also observed upon infection with either
VACV or vDC16 compared with mock-infected cells, but no
significant difference was observed between the two viruses,
suggesting that the metabolic differences between VACV and
vDC16 are specific to energy metabolism.
Taken together, the data presented show that, despite
some cell-specific differences affecting primarily compar-
ison to mock-infected cells, VACV induces a systematic
reprogramming of cell metabolism characterized by
increased nucleotide synthesis and extensive utilization of
glutamine. Possibly, glutamine may be used as the carbon
source to support the TCA cycle and the synthesis of new
molecules required for viral replication.
The differences between VACV and vDC16 show that protein
C16 contributes to reprogramming of central metabolism by
VACV, and in particular to increased utilization of glutamine.
Although increased utilization of glutamine is observed
during HIF-1a stabilization, the metabolic profile observed
differs from a canonical Warburg effect. This suggests either
that HIF-1a stabilization has different and more complex
metabolic consequences than increasing aerobic glycolysis,
particularly in promoting utilization of glutamine, as recently
reported by several studies (Metallo et al., 2012; Wise et al.,
2011), or that C16 acts on cell metabolism throughmore than
one mechanism.
DISCUSSION
VACV is a complex DNA virus that continues to provide
insight into pathogen–host interactions. VACV infection has
a dramatic impact on cells, but the metabolic alterations that
accompany the early stages of VACV infection have only
recently started to be investigated. Here, the metabolic
changes associated with VACV infection of HeLa and
2FTGH cells at early time points were examined, using a
combination of 1H-NMR spectroscopy and LC-MS, and the
consequence of C16-mediated stabilization of HIF-1a on
cellular metabolism was also studied.
A comparison of the response of HeLa and 2FTGH cells to
infection showed some cell-specific differences and several
similarities. The main differences were seen in comparison
with mock-infected cells, possibly reflecting a different
impact of viral replication of different metabolic back-
grounds. However, a remarkably conserved feature was
the increase in glutamine and nucleotide metabolism as
infection progressed from 1 to 5–7 h, and an even more
sustained induction of glutamine metabolism in the
presence of C16.
Previously we showed that early after infection, VACV
protein C16 induces stabilization of HIF-1a by inhibiting
the enzymatic activity of PHD2 (Mazzon et al., 2013). HIF-
1a is also stabilized by a wide range of pathogens (Carroll
et al., 2006; Darekar et al., 2012; McFarlane et al., 2011;
graphically to show the concentration of assigned metabolites at 7 h pi in VACV-infected, vDC16-infected or mock-infected
2FTGH cells. Concentrations are in mM. Data were analysed using a one-way ANOVA. *P,0.05; **P,0.01; ***P,0.001;
****P,0.0001.
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Nakamura et al., 2009; Nasimuzzaman et al., 2007; Werth
et al., 2010), and because infections can modulate several
signalling pathways, HIF-1a stabilization might contribute
to different metabolic outcomes in a context-dependent
manner. Whilst HIF-1a induces a shift towards glycolysis
in hypoxia (Semenza, 2012), its stabilization in normoxia is
known to have advantages beyond oxygen preservation.
Even though stabilization of HIF-1a was seen in both the
cell lines studied, evidence of a canonical Warburg effect,
i.e. increased lactate production and decreased TCA cycle
activity, markers of a metabolic shift towards glycolysis,
were not observed. Conversely, the activity of the TCA
cycle was preserved and was likely to have been promoted
by increased utilization of glutamine. To investigate
whether C16 has a role in metabolic changes, possibly
through stabilization of HIF-1a, the metabolic profiles of
cells infected with WT VACV or a virus lacking C16 (Fahy
et al., 2008; Mazzon et al., 2013) were studied and showed
that glutathione and intermediates of glutamine reductive
carboxylation (glutamine, glutamate and 2-HG) were
significantly higher in 2FTGH cells infected by VACV than
by vDC16. Conversely, no difference could be detected in
nucleotide or amino acid synthesis or in phosphocholine
metabolism, suggesting that these selective differences are
specific to pathways involved in central energy metabolism.
Particularly interesting was the accumulation of 2-HG,
predominantly in cells infected with VACV. 2-HG is an
onco-metabolite that is not normally observed in cells
unless isocitrate dehydrogenase is mutated, which has been
observed in several tumours. Increased concentration of
2-HG suggests enhanced reverse flux of a-ketoglutarate
through isocitrate dehydrogenase, and this phenomenon
can occur following increased utilization of glutamine
during HIF-1a stabilization (Wise et al., 2011).
Recent reports have shown that an increase in glutamine
utilization can be observed upon stabilization of HIF-1a
(Metallo et al., 2012; Mucaj et al., 2012; Mullen et al., 2012),
providing an alternative source of carbon to the TCA cycle
which, during hypoxia, becomes largely disconnected from
glycolysis (Daye & Wellen, 2012; Filipp et al., 2012; Sun &
Denko, 2014). Although this study does not enable clear
definition of the metabolic pathways that utilize glutamine
in VACV-infected cells, or of the role of HIF-1a in these
metabolic changes, our observations are consistent with a
model in which glutamine uptake and metabolism are
upregulated to provide the biosynthetic precursors normally
generated by glucose. However, due to the multi-functional
role of C16, which can also block DNA-PK-mediated innate
immune sensing by binding to the Ku complex (Ferguson
et al., 2012; Peters et al., 2013), further studies are needed to
understand whether other properties of this viral protein
contribute to reprogramming of cellular metabolism.
Utilization of glutamine by VACV has been reported
recently in two independent studies (Fontaine et al., 2014;
Greseth & Traktman, 2014). Consistent with our work,
these studies highlighted the importance of glutamine as
the main carbon source to preserve TCA cycle activity
during VACV infection. Both studies also showed that
whilst glutamine is required for viral protein synthesis,
glucose starvation does not affect VACV replication.
Although an increase in glycolysis was expected following
HIF-1a stabilization and from the increase in glucose
transporter 1 mRNA in cells infected with WT VACV
compared with vDC16 (Mazzon et al., 2013), consistent
with the results of Fontaine et al. (2014) and Greseth &
Traktman (2014), our data did not show any increase in
lactate production upon infection. However, increased
concentration of the glucose-derived metabolites UDP-
galactose and myo-inositol were observed (particularly
in VACV-infected cells) and, although measurement of
metabolite concentrations does not demonstrate unequi-
vocally the pathways involved in their synthesis, it is
possible that VACV uses glutamine to fuel the TCA cycle,
and glucose is used as a carbon source for additional
synthesis of nucleotides, phospholipids or macromolecules
important for energy storage. Shunting of glucose towards
biosynthetic pathways might explain in part why an
increase in glycolysis and lactate production was not
observed. A similar scenario has been described for human
cytomegalovirus, which upregulates glucose uptake; how-
ever, glucose, rather than being completely broken down in
the TCA cycle, is used biosynthetically for the synthesis of
fatty acids. As a consequence, uptake of glutamine also
increases and glutamine is converted into a-ketoglutarate
to maintain the activity of the TCA cycle (Vastag et al.,
2011; Yu et al., 2011).
In summary, this report shows that VACV infection increases
utilization of glutamine using a different technique (1H-
NMR) and two different cell lines. This study also
demonstrates that while a number of viral proteins may
influence the metabolic shift towards increased glutamine
utilization, VACV C16 contributes to this shift and promotes
the anabolic activity of infected cells. Mechanistically, protein
C16 binds to PHD2 and thereby stabilizes HIF-1a during
normoxia. However, HIF-1a stabilization does not promote
aerobic glycolysis or the Warburg effect during VACV
infection, but may instead contribute to the metabolic shift
towards increased glutamine metabolism induced by C16.
METHODS
Cell lines and viruses. HeLa cells were cultured in MEM with 10%
FBS and 1% (v/v) non-essential amino acids (Sigma). 2FTGH cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Life
Technologies) with 10% FBS. VACV strain WR and vDC16 lacking
both copies of gene C16L were described previously (Fahy et al.,
2008). Viruses were grown in BSC-1 cells and purified from
cytoplasmic extracts by sedimentation through a sucrose density
cushion. Virus stocks were stored at 280 uC and the infectious titre
was determined by plaque assay (Fahy et al., 2008).
Immunoblotting. Cells were lysed using a urea-based lysis buffer as
described (Mazzon et al., 2013). Primary antibodies used were: anti-
C16 rabbit serum (Fahy et al., 2008); anti-HIF-1a mouse monoclonal
(BD Biosciences); anti-tubulin mouse monoclonal (Upstate Biotech).
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Bound antibodies were detected using fluorescent-conjugated goat
anti-mouse or anti-rabbit secondary antibodies and infrared techno-
logy (Licor Biotechnology).
Quantitative PCR. Cells were infected at 10 p.f.u. per cell and at the
indicated times, DNA was extracted using a QiaAMP DNA mini kit
(Qiagen). PCR analysis using specific primers for VACV gene E9L was
performed with Fast SYBR Green Master Mix (Applied Biosystems)
and analysed on a ViiA 7 instrument using ViiA 7 RUO software
(Applied Biosystems). Primers used: DNA polymerase forward: 59-
ATGGATGTTCGGTGCATTAA; DNA polymerase reverse: 59-GC-
ATTAAATGGAGGAGGAGA.
Virus growth curves. Confluent cells were infected at 10 p.f.u. per
cell and harvested at 0, 12 and 24 h pi, and lysed by three freeze–
thawing cycles. The infectious virus titre was quantified by plaque
assay as described (Fahy et al., 2008).
Infection and metabolite extraction. Flasks of confluent HeLa or
2FTGH cells were infected at 10 p.f.u. per cell in MEM/1% FBS/1%
(v/v) non-essential amino acids (Sigma) and cells were harvested at
the indicated time points. Metabolites were extracted using a
methanol/chloroform/water procedure. Six hundred microlitres of
methanol/chloroform mix (2 : 1, v/v) were added to the cells and
samples were sonicated for 15 min at room temperature. Two
hundred microlitres each of chloroform and water were added, the
samples were centrifuged (16 100 g, 20 min) and the aqueous and
lipid phases were collected. The procedure was repeated twice, and
the aqueous and lipid fractions from each extraction were pooled. The
aqueous layer was dried overnight in an evacuated centrifuge.
NMR analysis of aqueous extracts. The dried extracts were
rehydrated in 600 ml D2O water, containing 0.05 mM sodium-3-(tri-
methylsylyl)-2,2,3,3-tetradeuteriopropionate (TSP; Cambridge Isotope
Laboratories) as an internal standard. The samples were analysed using
an AVANCE II+ NMR spectrometer operating at 500.13 MHz for the
1H frequency (Bruker) using a 5 mm TXI probe. Spectra were collected
using a solvent suppression pulse sequence based on a one-dimensional
nuclear Overhauser effect spectroscopy pulse sequence to saturate the
residual 1H water signal (relaxation delay52 s, t1 increment53 us,
mixing time5150 ms, solvent pre-saturation applied during the
relaxation time and the mixing time). One hundred and twenty-eight
transients were collected into 16 K data points over a spectral width
of 12 p.p.m. at 27 uC. In addition, generic cell samples were also
examined by two-dimensional spectroscopy, including Correlation
Spectroscopy, in conjunction with the Chenomix spectral database
contained in Chenomix NMR Suite 7.0 (Chenomx) for spectral
assignment.
NMR data processing. NMR spectra were processed using an ACD
one-dimensional NMR processor (version 12, ACD). Free induction
decays were Fourier transformed following multiplication by a line
broadening of 1 Hz, and referenced to TSP at 0.0 p.p.m. Spectra were
phased and the baseline was corrected manually. Each spectrum was
integrated using 0.02 p.p.m. integral regions between 0.5 and 4.5, and
5.5–8.5 p.p.m. The spectral region for each sample was scaled such
that the total sum of integrals for each sample was equal. The integrals
of the different metabolites were obtained using Chenomix.
Liquid chromatography MS analysis. LC-MS analysis used a 4000
QTRAP triple quadrupole mass spectrometer (Applied Biosystems/
Sciex), coupled to an Acquity UPLC (Waters) as described by Roberts
et al. (2012), except that an Aquity UPLC (Waters) was used and
multiple reaction monitoring parameters were added as outlined in
Table S5. Formic acid, ammonium acetate, LC-MS-grade solvents and
valine-d8 were from Sigma-Aldrich. Dried aqueous fractions from
HeLa and 2FTGH cells were prepared for LC-MS analyses by the
addition of 100 ml of 74.9 : 24.9 : 0.2 (by vol.) acetonitrile/methanol/
formic acid containing the stable isotope-labelled internal standard
valine-d8. Samples were vortexed, sonicated and the supernatants
were injected directly.
Multivariate analysis of metabolite profiles. The set of metabolic
profiles obtained was analysed by multivariate analysis. Datasets were
imported into SIMCA-P 12.0 (Umetrics) for processing using PCA
and PLS-DA, a regression extension of PCA used for supervised
classification. Briefly, in PLS-DA, the prior knowledge of class
membership is available and a dummy Y matrix is created, which
represents the class membership of each observation. A model is then
fitted between the X and Y variables. The plane found is therefore
discriminant because it maximizes the separation between classes. 1H-
NMR data were Pareto scaled, in which each variable was centred and
multiplied by 1/(Sk)1/2, where Sk is the standard deviation of the
variable. Graphs were processed with GraphPad Prism 5.
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